Immune Cell Lineage-Specific Chimerism Testing by Next-Generation Sequencing for Engraftment Monitoring After Allogeneic Hematopoietic Stem Cell …

C Wu, T dela Cruz, J Lai, D Kong… - Clinical Applications of …, 2023 - Springer
Chimerism is an unusual state in which a person's body comprises cells from genetically
different people. Chimerism testing allows monitoring for the relative proportion of recipient …

[HTML][HTML] Minimal residual disease monitoring by RQPCR of Ig/TCR rearrangements: an effective method to predict relapse in children with acute lymphoblastic …

VA Lavrinenko, AN Meleshko, DV Lutskovich… - Cell Ther …, 2018 - cyberleninka.ru
At the present time, clinical relapses remain the major cause of treatment failure in children
with acute lymphoblastic leukemia (ALL) treated by allogeneic hematopoietic stem cell …

Bone marrow engraftment studies

CL Vnencak‐Jones - Current protocols in human genetics, 2009 - Wiley Online Library
Bone marrow engraftment studies are used to evaluate the level of donor versus recipient
cells in post‐transplant peripheral blood or bone marrow specimens. Unique DNA …

[图书][B] Pediatric hematology: methods and protocols

NJ Goulden, CG Steward - 2008 - books.google.com
Much of the progress in the diagnosis, classification, and treatment of childhood
hematological disorders has come from a partnership between clinicians and scientists …

Haploidentical stem cell transplantation in childhood

P Bader, A Willasch, D Niethammer… - Current Cancer …, 2007 - ingentaconnect.com
Allogeneic stem cell transplantation has become an important treatment option for many
children with malignant and non malignant diseases during the past decades. However, this …

Severe acute graft-versus-host disease after T-cell depleted allogeneic stem cell graft from a second donor caused by persisting T-cells from the first donor

A Wiesmann, P Bader, M Bamberg, C Faul… - Bone marrow …, 2003 - nature.com
HLA disparity is a major risk factor for graft rejection and GVHD. We report a patient with
CML (accelerated phase) who underwent allogeneic SCT from a mismatched unrelated …

Rezidivprophylaxe bei Kindern mit ALL-, AML-und MDS nach allogener Stammzelltransplantation durch interventionelle Immuntherapie im kritischen Stadium eines …

JF Beck, T Klingebiel, H Kreyenberg… - Klinische …, 2002 - thieme-connect.com
Hintergrund: Rezidive sind die häufigste Todesursache für Kinder mit ALL, AML und MDS
nach allogener Stammzelltranplantation (allo-SZT). Durch engmaschige Chimärismus …

[PDF][PDF] Donor leukocyte infusions for the treatment of leukemia relapse after allogeneic hematopoietic cell transplantation with myeloablative conditioning

G Gürman - Turk J Haematol, 2000 - jag.journalagent.com
Leukemic relapse after allogeneic transplantation is a difficult problem. Conventional
treatment modalities or second transplants have not provided the sustained complete …

[HTML][HTML] Importancia del estudio del quimerismo en el trasplante alogénico de médula ósea

AM Amor Vigil, G Martínez Antuña - Revista Cubana de Hematología …, 2003 - scielo.sld.cu
Desde que se comenzó a realizar el trasplante hematopoyético se reconoció la importancia
de conocer el establecimiento de quimerismo. El presente trabajo actualiza los conceptos …

Chimerism in Hematopoietic Stem Cell Transplantation

DK Mishra, KR Patel, M Parihar, A Karpe - Contemporary Bone Marrow …, 2020 - Springer
The process of allogeneic hematopoietic stem cell transplantation is a complex and
systematic procedure which begins from donor selection and culminates in the successful …